Philip Morris International Inc. closed $16.60 below its 52-week high ($134.15), which the company reached on October 31st.
Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches.
We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...
Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...
Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products, stated, “In this case, ...
The Food and Drug Administration has authorized ZYN nicotine pouches, “making ZYN the first and only authorized nicotine pouch in the United ...
Philip Morris International Inc. PM has been making significant strides toward a smoke-free future. With a strong pricing ...
Philip Morris International Inc. (PM) stock saw a decline, ending the day at $117.15 which represents a decrease of $-4.71 or -3.87% from the prior close of $121.86. The stock opened at $119.96 and ...
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...